Search Filters

Search Results

Found 1 results

510(k) Data Aggregation

    K Number
    K960578
    Device Name
    ELVIS HSV GOLD
    Date Cleared
    1996-09-05

    (206 days)

    Product Code
    Regulation Number
    866.3305
    Reference & Predicate Devices
    N/A
    Why did this record match?
    Device Name :

    ELVIS HSV GOLD

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The Test Kit provides the cells and reagents necessary for detection and identification of HSV in patient specimens.

    Device Description

    The subject device consists of a mixed cell monolayer comprised of MRC-5 (Human Fetal Lung) and genetically modified Baby Hamster Kidney Cells (ELVIS™ HSV cells) which, when infected with HSV-1 or -2, are activated to produce and accumulate intracellularly the bacterial enzyme, beta-galactosidase. As in standard tube culture procedures, inoculated monolayers are examined daily for CPE. When CPE is observed, the monolayers are fixed and stained for the presence of beta-galactosidase. If blue cells are detected, indicating the presence of the enzyme which was induced by HSV, then the specimen is confirmed as being positive for HSV. If CPE is not detected by day 7 after inoculation, the monolayers are stained for the presence of pre-CPE, blue, HSV-infected cells. If none are found, the specimens are negative for HSV.

    AI/ML Overview

    Acceptance Criteria and Study Details for ELVIS™ HSV GOLD

    1. Acceptance Criteria and Reported Device Performance

    The acceptance criteria for the ELVIS™ HSV GOLD device were implicitly established through a non-inferiority comparison to existing "Gold Standard" tube culture methods. While explicit numerical thresholds for acceptance were not stated, the study aimed to demonstrate "substantial equivalence" in terms of clinical sensitivity and specificity.

    Performance MetricAcceptance Criteria (Implicit - Substantial Equivalence to "Gold Standard")Reported Device Performance (ELVIS™ HSV GOLD)
    Clinical SensitivityComparable to standard tube culture methods98.1%
    Clinical SpecificityComparable to standard tube culture methods98.7%

    2. Sample Size and Data Provenance

    • Sample Size (Test Set): Over 670 specimens.
    • Data Provenance: The specimens were "normally submitted to the respective institution for HSV testing," implying they were clinical samples from human patients. The study was conducted in 4 different laboratories, suggesting a multi-center study. The information does not explicitly state the country of origin but given the 510(k) submission to the FDA, it is highly likely the data originated from the United States. The statement "ELVIS™ HSV GOLD testing was performed on those specimens for which there was sufficient residual sample" suggests a prospective collection of data for the ELVIS™ HSV GOLD testing, using samples that were also tested with the predicate methods.

    3. Number of Experts and Qualifications for Ground Truth

    The provided text does not specify the number of experts used or their qualifications for establishing the ground truth for the test set.

    4. Adjudication Method for the Test Set

    The provided text does not specify an adjudication method. The ground truth was established by "predicate tests" which are "Classical 'Gold' standard tube culture methods... Confirmation, where used, is by fluorescent antibodies directed against HSV antigens." This implies the results of these predicate methods served as the ground truth.

    5. Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study

    A multi-reader multi-case (MRMC) comparative effectiveness study was not conducted as the device is a diagnostic test kit and not an AI-based system assisting human readers. Therefore, there is no effect size reported for human readers in conjunction with AI.

    6. Standalone Performance

    Yes, a standalone study was performed. The reported clinical sensitivity of 98.1% and clinical specificity of 98.7% for the ELVIS™ HSV GOLD test are measures of its performance as a standalone diagnostic device.

    7. Type of Ground Truth Used

    The ground truth used was expert consensus / predicate method. Specifically, the "Classical 'Gold' standard tube culture methods commonly used by many clinical laboratories for isolation and identification of HSV." This includes confirmation by fluorescent antibodies where necessary.

    8. Sample Size for the Training Set

    The provided text does not specify a training set size. This is a diagnostic test kit based on biological assays, not a machine learning algorithm, so a "training set" in the computational sense is not applicable. The development of the device likely involved internal optimization and validation, but this is distinct from a machine learning training set.

    9. How Ground Truth for the Training Set was Established

    As there is no "training set" in the context of a machine learning algorithm, the concept of establishing ground truth for a training set is not applicable here. The inherent biological mechanisms of the ELVIS™ HSV GOLD system (genetically modified cells, beta-galactosidase induction) were developed and optimized based on known characteristics of HSV infection and cellular responses, rather than being "trained" on a dataset in the AI sense.

    Ask a Question

    Ask a specific question about this device

    Page 1 of 1